Apollon
About:
Apollon develops noninvasive continuous glucose monitoring systems.
Website: https://www.apollon.bio
Top Investors: TIPS Program, KB Investment, TheVentures, STIC Ventures, Future Science and Technology Holdings
Description:
Total Funding Amount:
$2.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2021-06-21
Contact Email:
aram(AT)apollon.bio
Founders:
Aram Hong
Number of Employees:
11-50
Last Funding Date:
2024-04-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai